Join Index
For Startups
For Investors
For Brands
For Analysts
Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Relmada Therapeutics
1457
Relmada Therapeutics
Technology
Biotechnology
Relmada (OTCQB: $RLMD) is focused on developing novel versions of proven drug products together with new chemical entities for the treatment of chronic pain.
Suggest edits
Founded
2007
Raised
$18.1M
Follow us
Also headquartered in New York
Verizon
IBM
HBO
Kickstarter
Wired
Goldman Sachs
Bloomberg
JPMorgan
Time Warner
The New York Times
Companies in the same industry
Regulus Therapeutics
eBioscience, Inc.
Volcano Corporation
Histogenics Corporation
X-STATIC ®
Sorrento Therapeutics, Inc.
HTG Molecular
Diagnosoft Inc.
E Ink Holdings
WellAWARE Systems
Alexa global traffic share
